After living an average Aussie life playing sport, spending languid days on the beach, and falling in love with ocean swimming, Anne Gately was diagnosed with a melanoma in 2010. The melanoma was removed and test results confirmed the cancer had not spread.
2025
NCCN Guidelines Update Includes HEPZATO KIT for Uveal Melanoma
Updates to the NCCN guidelines recommend HEPZATO KIT for use in hepatic-dominant uveal melanoma as a Category 2A treatment option.
Can a simple blood test spot the signs of skin cancer returning?
A BURY-BORN mum diagnosed with skin cancer after a chance encounter is helping researchers to trial a pioneering blood test that can spot signs of melanoma returning.
Lifileucel Approval Paves the Way for Personalized Minimally-Invasive T-Cell Therapies
The FDA’s accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.